procedure that is associated with virtually no mortality and with an acceptable morbidity incidence (usually less than 10%). Recently, however, the value of staging laparotomy* has been questioned by some oncologists. At a few institutions, staging laparotomy is not peformed at all," 2 whereas at other centers it is performed on a very selective basis. 36 We evaluated the results with staging laparotomy in 255 patients with Hodgkin's disease in order to evaluate its accuracy as a diagnostic procedure and then to analyze which prognostic factors best predict the risk of abdominal disease. Our objective was to establish a quantitative estimate for abdominal Hodgkin's disease that could be used in making decisions about a staging laparotomy in an individual patient setting. Such information might enable a better selection of those patients with either a very low or a very high risk of abdominal disease so that treatment decisions might be considered in selected patients without a laparotomy.
Materials and Methods
The data for all 425 patients with Hodgkin's lymphoma treated at the University of Alabama at Birmingham between November 1943 through January 1983 were compiled into a computerized data base. Of these, 255 patients had a staging laparotomy, which was incorporated into the diagnostic work-up beginning in 1967. These operations were performed both at the University of Alabama at Birmingham and in other * A more proper terminology is staging celiotomy. Total  IA  IB  IIA  IIB  IIIA  IIIB  IVA  IVB  Total  255  48  6  85  24  40  34  4  14   IA  48  39  1  7  1  IB  15  6  0  5  4   Clinical   IIA  89   1  71  15  2  Stage  IIB  42  0  18  15  9   IIIA  40  8  13  18  1  IIIB  21  0  6 Table 3 . The spleen was most frequently involved (71%), while periaortic nodes were involved in 41% of these patients and the splenic hilar lymph nodes contained disease in 18% of patients. Bone marrow biopsy yielded occult Hodgkin's disease in 18 patients (7%). (Table 6 ).
Follow-up Results
To estimate the accuracy of staging laparotomy, the risk for abdominal relapse was analyzed in patients undergoing long-term follow-up whose staging laparotomy showed no detectable evidence of Hodgkin's disease (pathological stage I or II). There were 135 patients who had negative laparotomies; as a result, they did not receive abdominal irradiation. Of these, 16 (12%) relapsed in the abdomen. The median time for relapse was 1.9 years. Some patients relapsed at more than one site. The mean follow-up of all patients was 4.8 years, a time period during which more than 85% of relapsed patients had already developed a recurrence. The most common sites of relapse for these 16 patients were the periaortic lymph nodes (50%), iliac lymph nodes (31%), or bone marrow (25%) as shown in Table 7 . Based upon these (Table 6 ). Johnson and colleagues4 also suggested that stage I and II NS patients (especially asymptomatic ones) had a sufficiently low risk for distant disease that they should be treated with radiation therapy and not undergo a laparotomy.
Second, there was an identifiable high-risk group of patients where the probability of abdominal disease is so high (69% to 93%) that it could be assumed to be present, and the patients treated with chemotherapy (and possibly radiation therapy) for occult disseminated disease. This selection might include symptomatic patients with LD histology (especially males), or On the other hand, those patients who are understaged might be undertreated as well, with a diminished probability for cure when they relapse. As with many controversies in medicine, the issue is not "all or none" and there may be an intermediate position that some, but not all, patients require a laparotomy in order to make a proper treatment decision in an individual patient.
Staging laparotomy is a safe and accurate diagnostic tool for directing more specific therapy in Hodgkin's disease patients. The operative mortality should approach zero per cent and the morbidity should be less than ten per cent.' 1, 17, 18, [22] [23] [24] It is entirely possible that a more selective approach would be feasible in the future, and that patients with especially high and low risks for abdominal disease based upon prognostic factors could have their treatment decisions made without having to undergo a staging laparotomy. In our opinion, it is still an appropriate and necessary procedure for the large number of patients with intermediate risk for abdominal disease as listed in Table 6 .
The approach described here provides .a quantitative estimate of risk for abdominal disease that the physician can use in combination with other aspects of clinical judgment (e.g., number of sites, extent, risk for surgery, number of treatment options, etc.) to make a more considered decision for an individual patient. While the probability of abdominal involvement may vary from one series to another, it does provide a mechanism for comparison between institutions and could be used to determine stratification criteria in clinical trials.
